Table 2.
Condition | Source | Animal | Results | Refs. |
---|---|---|---|---|
Genetically modified MSCs | ||||
DSS-induced colitis | BM | BALB/c mice | Better homing to the colon and spleen of mice models leads to the reduced Th1 and Th17 cells but improving the Tregs numbers by ICAM-1-overexpressing MSCs | [30] |
TNBS-induced colitis | BM | BALB/c mice | Improved homing to the intestinal mucosa and thus causing a more appreciated curative effect by CXCR‑4-overexpressing MSCs | [161] |
TNBS-induced colitis | BM | BALB/c mice | More powerful migration to the inflamed colons, causing a strong anti-inflammatory effect by CXCR2-overexpressing MSCs | [162] |
DSS-induced colitis | BM | C57BL/6 mice | Down-regulation of miR-141 and miR-139 expression but a promoting ICAM-1 and CXCR4 expression in H19-overexpressing MSCs compared with naïve MSCs | [164] |
DSS-induced colitis | Hair follicle | SD rats | Improving intestinal stem cells proliferation (ISC), attenuating inflammatory factors levels, promoting the anti-inflammatory factors, and also reducing DAI score by Nrf-2-overexpressing MSCs | [166] |
DSS-induced colitis | DP | SD rats | Transdifferentiation of the HGF-overexpressing MSCs into ISC-like cells and suppressing inflammatory responses as well as oxidative stress | [82] |
TNBS-induced colitis | DP | BALB/c mice | Promoting the colon length and supporting intestinal mucosa architecture by enhancing M2 but not M1 macrophage polarization by HIF-1-overexpressing MSCs | [168] |
DSS-induced colitis | BM | C57BL/6 mice | Promoting the Tregs and Th2 cells and improving the IDO expression in colon tissue colon by IFN-γ-overexpressing MSCs | [169] |
DSS-induced colitis | BM | BALB/c mice | Improving the Tregs population in colon tissue by IL-35 overexpressing MSCs | [170] |
DSS-induced colitis | BM | SD rats | Improved homing and robust anti-inflammatory response by CX3CR1/IL-25 dual expressing MSCs | [26] |
DSS-induced colitis | UC | CD11b-DTR mice | Suppression of 15-lox-1 expression in macrophage by miR148b-5p-overexpressing MSCs | [245] |
TNBS-induced colitis | BM | SD rats | Supporting the colonic morphology and amelioration of tissue structure by KGF-overexpressing MSCs | [246] |
Pre-treated MSCs | ||||
DSS-induced colitis | UC | C57BL/6 mice | Amelioration of the clinical signs of disease and reducing colon shortening by poly(I: C)-pre-treated MSCs | [143] |
DSS-induced colitis | UC | C57BL/6 mice | Enhancing COX-2, IL-6, and IL-8 expression and targeting macrophage polarization by IL-1β pre-treated MSCs | [145] |
DSS-induced colitis | BM | SD rats | Suppression of the Th17 immune response and promoting T regulatory cell phenotype by IL-25-pre-treated MSCs | [148] |
DSS-induced colitis | Tonsil | C57BL/6J mice | Potentiating the immunomodulatory potential via up-regulation of the COX-2/PGE2 axis in TNF-ɑ pre-treated MSCs | [139] |
TNBS-induced colitis | UC | BALB/c mice | Enhancing the therapeutic competence of MSCs due to the activation of the TLR3–Jagged–1-Notch-1 pathway in poly I: C-pre-treated MSCs | [144] |
DSS-induced colitis | BM | C57BL/6 mice | Attenuation of immune cell infiltration and inflammatory cytokines levels in colon tissue by IFN-γ- and poly I: C-pre-treated MSCs | [152] |
DSS and DNBS-induced colitis | AT | C57BL/6 mice | Secretion of higher levels of TSG-6 and PGE2 by MSCs upon priming with TNF-ɑ leading to the stimulation of phenotypic alterations in macrophages | [19] |
MSCs mesenchymal stem/stromal cells, BM bone marrow, UC umbilical cord, AT adipose tissue, DP dental pulp, TNBS 2,4,6-trinitrobenzene sulfonic acid, DSS dextran sulfate sodium, Th T helper 1/2/17, FOXP3 Forkhead box P3, IL-1 interleukin-1β, TNF-α tumor necrosis factor-alpha, PGE2 prostaglandin E2, Tregs regulatory T cells, IDO indoleamine 2,3-dioxygenase, IFN-γ interferon-gamma, IL interleukin, TLRs toll-like receptors, ICAM-1 intercellular adhesion molecule-1, CXCR-4 C-X-C chemokine receptor type 4, TSG6 TNFα-stimulated gene-6, KGF keratinocyte growth factor, CX3CR1 CX3C chemokine receptor 1, MCP-1/CCL2 monocyte chemoattractant protein-1, HGF hepatocyte growth factor, NRF2 nuclear factor erythroid 2-related factor 2, miRNAs microRNAs